EISSN 2148-5607

TJG is categorized as Q3 in JIF. TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.6

Turkish Journal of Gastroenterology

36 433 2025

HIGHLY CITED ARTICLES

Correlation Between Kidney Function and Intestinal Biological Characteristics of Adenine and Folium SennaeInduced Diarrhea Model in Mice

Xiaoya Li, Jiayuan Zhu, Yi Wu, Zhoujin Tan

Management of Primary Biliary Cholangitis: Current Treatment and Future Perspectives

Bernel et al.

Coffee-Derived Exosome-Like Nanoparticles: Are They the Secret Heroes?

Kantarcıoğlu et al.

Epigenetics of Inflammatory Bowel Diseases

Törüner and Ünal

Vonoprazan on the Eradication of Helicobacter pylori Infection

Huang and Lin

Acute Pancreatitis Review

Huang and Badurdeen

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

Submission to First Decision = 31 Days

Letters to the Editor

Rare Side Effect Due to Vedolizumab in a Patient with Ulcerative Colitis: Catatonic Depression

Ozan Durmaz ¹ , Adnan Ozkahraman ¹ , Yusuf Kayar ¹

Author Affiliation(s)

1.

Division of Gastroenterology, Department of Internal Medicine, Van Education and Research Hospital, Van, Türkiye

Turk J Gastroenterol 2025; 1: -

DOI: 10.5152/tjg.2025.25210

Read: 167 Downloads: 161 Published: 09 October 2025

Volume 1, Issue 1, January 2025

Previous Article

Cite this article as: Durmaz O, Ozkahraman A, Kayar Y. Rare side effect due to vedolizumab in a patient with ulcerative colitis: catatonic depression. Turk J Gastroenterol. Published online October 9, 2025. doi:10.5152/tjg.2025.25210.

Files